2022, Number 2
Cardiovasc Metab Sci 2022; 33 (2)
Case report: COVID-19 mRNA vaccine association with acute myocarditis
Pérez-Orpinel, Oscar A; Figuerola-Chaparro, Luis C; Fernández-Rosas, Susana; Moreno-Zamudio, Daniela; Mendoza-González, Celso A
ABSTRACTA 50-year-old woman presented to the Emergency Department with chest pain, the elevation of cardiac enzymes, and no electrocardiographic alterations. Coronary angiography was performed in which no obstructive lesions were found. A cardiac magnetic resonance study reported an image consistent with acute myocarditis without evidence of myocardial ischemia. The patient received the first dose of Pfizer-BioNTech vaccine two days before the onset of symptoms. In most cases of myocarditis, its clinical manifestations lie in a wide spectrum, and the etiological diagnosis is indeterminate. In recent months, the probable association between cases of myocarditis with COVID-19 mRNA vaccines has been established. The use of the COVID-19 mRNA vaccine has demonstrated significant benefits in reducing morbidity and mortality related to SARS-CoV-2 virus infection. This event may be a transitory process that does not represent a contraindication for the application of the vaccine.